Overview

Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China

Status:
Completed
Trial end date:
2017-10-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the Pharmacokinetics and Safety of single dose of Ravidasvir and Danoprevir/r and repeated doses of Ravidasvir in combination with Danoprevir/r in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Ascletis Pharmaceuticals Co., Ltd.
Treatments:
Lactams
Ritonavir